Cargando…

Field testing of the ICHD-3β and expert opinion criteria for chronic migraine

BACKGROUND: Chronic headache (CrH) occurs commonly in the population, and chronic migraine (CM) accounts for much of the CrH. Diagnostic criteria for CM remain controversial, and this could lead to undertreatment of CM. The purpose of this study was to analyze the clinical profiles of CM and to fiel...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Huahua, Deng, Yong, Zhang, Yixin, Jin, Jieli, Kong, Xueying, Zhu, Qiuwen, Wang, Kuiyun, Zhou, Jiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028349/
https://www.ncbi.nlm.nih.gov/pubmed/27644255
http://dx.doi.org/10.1186/s10194-016-0678-x
_version_ 1782454351972794368
author Jiang, Huahua
Deng, Yong
Zhang, Yixin
Jin, Jieli
Kong, Xueying
Zhu, Qiuwen
Wang, Kuiyun
Zhou, Jiying
author_facet Jiang, Huahua
Deng, Yong
Zhang, Yixin
Jin, Jieli
Kong, Xueying
Zhu, Qiuwen
Wang, Kuiyun
Zhou, Jiying
author_sort Jiang, Huahua
collection PubMed
description BACKGROUND: Chronic headache (CrH) occurs commonly in the population, and chronic migraine (CM) accounts for much of the CrH. Diagnostic criteria for CM remain controversial, and this could lead to undertreatment of CM. The purpose of this study was to analyze the clinical profiles of CM and to field test the International Classification of Headache Disorders-3β criteria (ICHD-3β) and Expert Opinion criteria (EO) for CM application. METHODS: We retrospectively reviewed the medical records of CrH patients in our headache clinic during the period. Eligible patients were selected from CrH population based on Silberstein and Lipton criteria (S-L) for CM, and meanwhile fulfilled with migraine days at least 8 days/month. Then we evaluated the characteristics of clinic profiles and outcomes between patients diagnosed CM using ICHD-3β and EO criteria. Field tested the CM criteria Of ICHD-3β and EO. RESULTS: In a total of 710 CrH patients , 261 (36.8 %) were recruited with CM based on both S-L criteria and fulfilled at least 8 migraine days/month. Be understandable, all the 261 patients met the EO criteria, and only 185 (70.9 %) met ICHD-3β for CM. For the 76 patients who met EO but not ICHD-3β, 70 had atypical migraine attacks (probable migraine, PM), and another 6 had typical migraine attacks but less than a total history of 5 attacks. Although 173 (66.3 %) were concurrent with medication overuse, just one patient overused triptans and none used ergot agents. Clinical features were not significantly different between the ICHD-3β and EO criteria groups (P > 0.05), and neither were outcomes of prophylaxis (P = 0.966). Total migraine prophylaxis effectiveness was 73 %. CONCLUSION: Migraine-specific analgesics are rarely used in China, permitting patients with PM to avail themselves of “migraine days” is a reasonable accommodation for this difficult condition. In our hands, use of the new EO criteria for diagnosis of CM increases the sensitivity and maintains the specificity of decision making, and therefore should be adopted in CM management practice.
format Online
Article
Text
id pubmed-5028349
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-50283492016-10-03 Field testing of the ICHD-3β and expert opinion criteria for chronic migraine Jiang, Huahua Deng, Yong Zhang, Yixin Jin, Jieli Kong, Xueying Zhu, Qiuwen Wang, Kuiyun Zhou, Jiying J Headache Pain Research Article BACKGROUND: Chronic headache (CrH) occurs commonly in the population, and chronic migraine (CM) accounts for much of the CrH. Diagnostic criteria for CM remain controversial, and this could lead to undertreatment of CM. The purpose of this study was to analyze the clinical profiles of CM and to field test the International Classification of Headache Disorders-3β criteria (ICHD-3β) and Expert Opinion criteria (EO) for CM application. METHODS: We retrospectively reviewed the medical records of CrH patients in our headache clinic during the period. Eligible patients were selected from CrH population based on Silberstein and Lipton criteria (S-L) for CM, and meanwhile fulfilled with migraine days at least 8 days/month. Then we evaluated the characteristics of clinic profiles and outcomes between patients diagnosed CM using ICHD-3β and EO criteria. Field tested the CM criteria Of ICHD-3β and EO. RESULTS: In a total of 710 CrH patients , 261 (36.8 %) were recruited with CM based on both S-L criteria and fulfilled at least 8 migraine days/month. Be understandable, all the 261 patients met the EO criteria, and only 185 (70.9 %) met ICHD-3β for CM. For the 76 patients who met EO but not ICHD-3β, 70 had atypical migraine attacks (probable migraine, PM), and another 6 had typical migraine attacks but less than a total history of 5 attacks. Although 173 (66.3 %) were concurrent with medication overuse, just one patient overused triptans and none used ergot agents. Clinical features were not significantly different between the ICHD-3β and EO criteria groups (P > 0.05), and neither were outcomes of prophylaxis (P = 0.966). Total migraine prophylaxis effectiveness was 73 %. CONCLUSION: Migraine-specific analgesics are rarely used in China, permitting patients with PM to avail themselves of “migraine days” is a reasonable accommodation for this difficult condition. In our hands, use of the new EO criteria for diagnosis of CM increases the sensitivity and maintains the specificity of decision making, and therefore should be adopted in CM management practice. Springer Milan 2016-09-19 /pmc/articles/PMC5028349/ /pubmed/27644255 http://dx.doi.org/10.1186/s10194-016-0678-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Jiang, Huahua
Deng, Yong
Zhang, Yixin
Jin, Jieli
Kong, Xueying
Zhu, Qiuwen
Wang, Kuiyun
Zhou, Jiying
Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title_full Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title_fullStr Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title_full_unstemmed Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title_short Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
title_sort field testing of the ichd-3β and expert opinion criteria for chronic migraine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028349/
https://www.ncbi.nlm.nih.gov/pubmed/27644255
http://dx.doi.org/10.1186/s10194-016-0678-x
work_keys_str_mv AT jianghuahua fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT dengyong fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT zhangyixin fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT jinjieli fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT kongxueying fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT zhuqiuwen fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT wangkuiyun fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine
AT zhoujiying fieldtestingoftheichd3bandexpertopinioncriteriaforchronicmigraine